Saturday 17 October 2026
Export PETS’s income statement to Excel — free account
PetMed Express, Inc.
PETS Healthcare Pharmaceutical Retailers
PetMed Express, Inc.’s revenue for fiscal 2026 (year ended March 2026) was $179.0 million, down 21.1% from fiscal 2025. In the quarter to June 2026, revenue fell 19.9%, EPS grew 83.0% and free cash flow grew 38.6%, each against the same quarter a year earlier. Dividend growth for ten consecutive years; insiders bought in the last twelve months.
1.20
0.02
−1.64%
Follow PETS
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
(78.90%) | (100.63%) | (100.45%) | (78.58%) | |
Piotroski F-Score |
2 | 3 | 3 | 3 | |
| (44.67%) | (55.74%) | (49.84%) | (33.73%) | ||
ROIC |
(439.47%) | (630.14%) | (487.12%) | (194.08%) | |
Return on Tangible Assets |
(176.87%) | (304.68%) | (320.82%) | (239.60%) | |
Average Days of Receivables |
3.62 | 3.04 | 3.89 | 3.69 | |
Free Cash Flow per Share |
(0.75) | (1.09) | (1.58) | (1.28) | |
Free Cash Flow |
(15.68) | (22.92) | (33.01) | (27.77) | |
Capital Expenditures |
(7.08) | (6.28) | (4.61) | (3.96) | |
| Other line items | |||||
Cash ROIC |
(19.81%) | (38.41%) | (65.56%) | (77.00%) | |
Accounts Receivable Turnover |
110.61 | 97.94 | 84.74 | 102.00 | |
Accounts Payable Turnover |
7.77 | 8.67 | 5.79 | 7.53 | |
Inventory Turnover |
10.06 | 11.29 | 8.64 | 9.07 | |
Average Days of Payables |
49.80 | 54.69 | 59.24 | 36.88 | |
Days of Inventory on Hand |
38.47 | 32.88 | 38.56 | 25.40 | |
Tax Rate |
0.13 | 0.10 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
35.53% | 39.03% | 40.36% | 40.67% | |
Share Based Compensation of Revenue |
0.95% | 0.90% | 0.76% | 0.58% | |
Operating CF/Net income |
0.16 | 0.26 | 0.50 | 0.81 | |
Depreciation/Fixed assets |
0.33 | 0.37 | 1.39 | 0.37 | |
Capex/Depreciation |
(0.75) | (0.61) | (0.13) | (0.43) | |
Revenue per Share |
9.49 | 8.90 | 8.56 | 7.79 | |
Operating CF per Share |
(0.41) | (0.79) | (1.36) | (1.10) | |
Capex per Share |
(0.34) | (0.30) | (0.22) | (0.18) | |
Capex to Sales |
0.04 | 0.03 | 0.03 | 0.02 |
Columns are period end dates